GRI Bio Presents New Phase 2a Data at ERS 2026 Defining GRI-0621's Mechanism of Action in IPF Across Nine Mechanistic Pillars

New whole-blood RNA sequencing data identified coordinated and consistent gene-expression changes associated with immune re-balancing, myofibroblast inhibition, fibrolysis, basement-membrane repair and re-epithelialization. The findings also indicated potential antitussive and gastrointestinal-protective effects, providing supportive mechanistic evidence but no clinical efficacy, financial, or regulatory data.